3,3-difluoro-1-(1H-1,2,3-triazol-5-yl)cyclobutan-1-amine dihydrochloride

Catalog No.: 
ACNEXS386
CAS No.: 
2316459-16-0
Molecular Formula: 
C6H8F2N4.2ClH
Molecular Weight: 
246.03
3,3-difluoro-1-(1H-1,2,3-triazol-5-yl)cyclobutan-1-amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$440.00In stockInquiry
250mg97%$701.00In stockInquiry
500mg97%$1169.00In stockInquiry
1g97%$1753.00In stockInquiry
5g97%$5257.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,3-difluoro-1-(1H-1,2,3-triazol-5-yl)cyclobutan-1-amine dihydrochloride
IUPAC Name3,3-difluoro-1-(1H-1,2,3-triazol-5-yl)cyclobutan-1-amine dihydrochloride
MDL No.MFCD32670505
Molecular FormulaC6H8F2N4.2ClH
Molecular Weight246.03
SMILESFC1(F)CC(C1)(N)C2=CN=NN2.Cl.Cl
InChI KeyJUBOFPRGGADZHT-UHFFFAOYSA-N
Synonym2316459-16-0 | 3,3-difluoro-1-(1H-triazol-5-yl)cyclobutanamine | dihydrochloride | 3,3-Difluoro-1-(1H-1,2,3-triazol-5-yl)cyclobutan-1-amine dihydrochloride | 3,3-Difluoro-1-(2H-triazol-4-yl)cyclobutan-1-amine | SCHEMBL21296632 | MFCD32670505 | AT10568 | B
CAS No.2316459-16-0
PubChem CID139434809

Synthetic Route by SureRoute

1. ACNEXS386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEXS386 route product structure diagram
    ACNEXS3862316459-16-0In Stock
Inquiry

2. ACNEXS386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEXS386 route product structure diagram
    ACNEXS3862316459-16-0In Stock
Inquiry

3. ACNEXS386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNEXS386 route product structure diagram
    ACNEXS3862316459-16-0In Stock
Inquiry

Comments (0)